Phase II study of continuous 120-hour-infusion of mitomycin C as salvage chemotherapy in patients with progressive or rapidly recurrent gastrointestinal adenocarcinoma. - Hartmann,J.T.; Kanz,L.; Bokemeyer,C. (Anticancer Res, 2000)